AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Sale
+$126,580
-0.15%
Shares
Shares Volume: 7,867 Shares
Average Share Price: $16.09
INSIDER
Adjuvant Global Health Technology Fund, L.P.
10% Owner
reported on Sep 29 2023
traded on Sep 27 2023
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 5,168,682 |
| PURCHASES/SALES 1Y | 0 / 8 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $34,734.97 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 2 / 18 |
| P/S VALUE RATIO | 28.878 |
| AVERAGE SALE VALUE | $30,884.05 |
| COMPANY PREVIOUS TRADES |